NO20030393D0 - Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler - Google Patents
Effektiv ligand-mediert Ullmann-kobling av aniliner og azolerInfo
- Publication number
- NO20030393D0 NO20030393D0 NO20030393A NO20030393A NO20030393D0 NO 20030393 D0 NO20030393 D0 NO 20030393D0 NO 20030393 A NO20030393 A NO 20030393A NO 20030393 A NO20030393 A NO 20030393A NO 20030393 D0 NO20030393 D0 NO 20030393D0
- Authority
- NO
- Norway
- Prior art keywords
- azoles
- anilines
- ullmann coupling
- efficient ligand
- mediated ullmann
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Executing Machine-Instructions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22093200P | 2000-07-26 | 2000-07-26 | |
PCT/US2001/023541 WO2002008199A2 (en) | 2000-07-26 | 2001-07-26 | Efficient ligand-mediated ullmann coupling of anilines and azoles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030393D0 true NO20030393D0 (no) | 2003-01-24 |
NO20030393L NO20030393L (no) | 2003-03-24 |
Family
ID=22825611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030393A NO20030393L (no) | 2000-07-26 | 2003-01-24 | Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler |
Country Status (22)
Country | Link |
---|---|
US (1) | US6541639B2 (no) |
EP (1) | EP1307431B1 (no) |
JP (1) | JP2004504384A (no) |
KR (1) | KR20030060872A (no) |
CN (1) | CN1444565A (no) |
AT (1) | ATE307804T1 (no) |
AU (1) | AU2001280813A1 (no) |
BR (1) | BR0112746A (no) |
CA (1) | CA2417426A1 (no) |
DE (1) | DE60114424T2 (no) |
EC (1) | ECSP034453A (no) |
ES (1) | ES2251501T3 (no) |
HU (1) | HUP0301699A3 (no) |
IL (1) | IL153547A0 (no) |
IS (1) | IS6695A (no) |
MX (1) | MXPA03000686A (no) |
NO (1) | NO20030393L (no) |
NZ (1) | NZ523271A (no) |
PL (1) | PL361233A1 (no) |
RU (1) | RU2003103706A (no) |
WO (1) | WO2002008199A2 (no) |
ZA (1) | ZA200300039B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1390340T3 (en) * | 2001-04-24 | 2017-05-15 | Massachusetts Inst Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
ES2373875T3 (es) * | 2002-03-05 | 2012-02-09 | Transtech Pharma, Inc. | Derivados de azol mono y bicíclicos que inhiben la interacción de ligandos con rage. |
CN1668595A (zh) * | 2002-05-31 | 2005-09-14 | 罗狄亚化学公司 | 形成碳-碳或碳-杂原子键的方法 |
AU2003257062A1 (en) * | 2002-08-02 | 2004-02-23 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
WO2004031143A2 (en) * | 2002-10-02 | 2004-04-15 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
AU2004251599A1 (en) * | 2003-05-20 | 2005-01-06 | Transtech Pharma, Inc. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
US20090012300A1 (en) * | 2004-07-16 | 2009-01-08 | Mathilda Maria Henrica Lambers | Process for the Preparation of an (Hetero) Arylamine |
CN101796051B (zh) * | 2007-03-12 | 2013-11-06 | 细胞内治疗公司 | 与取代的杂环稠合的γ-咔啉的合成 |
CA2772797C (en) | 2009-09-30 | 2018-09-25 | Transtech Pharma, Inc. | Substituted imidazole derivatives |
RU2014145682A (ru) | 2012-04-14 | 2016-06-10 | Интра-Селлулар Терапиз, Инк | Органические соединения |
EP2968320B1 (en) | 2013-03-15 | 2020-11-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2015085004A1 (en) | 2013-12-03 | 2015-06-11 | Intra-Cellular Therapies, Inc. | Novel methods |
EP3125892A4 (en) | 2014-04-04 | 2017-12-27 | Intra-Cellular Therapies, Inc. | Organic compounds |
KR20220054908A (ko) | 2014-04-04 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
WO2015171951A1 (en) * | 2014-05-07 | 2015-11-12 | The Regents Of The University Of Colorado, A Body Corporate | 2-(4-aryl-1h-imidazol-1-yl)aniline compounds |
IL296884B2 (en) | 2016-01-26 | 2024-05-01 | Intra Cellular Therapies Inc | Condensed heterocyclic converted gamma carbonyls for use in the treatment of central nervous system disorders |
CN113754661A (zh) | 2016-03-25 | 2021-12-07 | 细胞内治疗公司 | 有机化合物 |
EP3436016B1 (en) | 2016-03-28 | 2022-04-27 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
EP3436083A4 (en) | 2016-03-28 | 2019-11-27 | Intra-Cellular Therapies, Inc. | NEW COMPOSITIONS AND METHODS |
WO2017172784A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel salts and crystals |
WO2018071233A1 (en) | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
US10961245B2 (en) | 2016-12-29 | 2021-03-30 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders |
WO2018126143A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
BR112019019875A2 (pt) | 2017-03-24 | 2020-04-22 | Intra Cellular Therapies Inc | novas composições e métodos |
EP3658144B1 (en) | 2017-07-26 | 2022-01-26 | Intra-Cellular Therapies, Inc. | Pyridopyrroloquinoxaline compounds, their compositions and uses in therapy |
US11376249B2 (en) | 2017-07-26 | 2022-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
JP7268049B2 (ja) | 2018-03-08 | 2023-05-02 | インサイト・コーポレイション | PI3K-γ阻害剤としてのアミノピラジンジオール化合物 |
KR20210031455A (ko) | 2018-06-11 | 2021-03-19 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
WO2020047407A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
US10695345B2 (en) | 2018-08-31 | 2020-06-30 | Intra-Cellular Therapies, Inc. | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6372658A (ja) | 1986-09-17 | 1988-04-02 | Sumitomo Chem Co Ltd | ニトロジフエニルアミン類の製造方法 |
US5705697A (en) | 1997-01-30 | 1998-01-06 | Xerox Corporation | Arylamine processes |
ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
-
2001
- 2001-07-25 US US09/912,950 patent/US6541639B2/en not_active Expired - Fee Related
- 2001-07-26 AT AT01959231T patent/ATE307804T1/de not_active IP Right Cessation
- 2001-07-26 BR BR0112746-2A patent/BR0112746A/pt not_active IP Right Cessation
- 2001-07-26 NZ NZ523271A patent/NZ523271A/en unknown
- 2001-07-26 CA CA002417426A patent/CA2417426A1/en not_active Abandoned
- 2001-07-26 CN CN01813378A patent/CN1444565A/zh active Pending
- 2001-07-26 JP JP2002514105A patent/JP2004504384A/ja active Pending
- 2001-07-26 DE DE60114424T patent/DE60114424T2/de not_active Expired - Fee Related
- 2001-07-26 EP EP01959231A patent/EP1307431B1/en not_active Expired - Lifetime
- 2001-07-26 PL PL36123301A patent/PL361233A1/xx not_active Application Discontinuation
- 2001-07-26 WO PCT/US2001/023541 patent/WO2002008199A2/en active IP Right Grant
- 2001-07-26 MX MXPA03000686A patent/MXPA03000686A/es unknown
- 2001-07-26 AU AU2001280813A patent/AU2001280813A1/en not_active Abandoned
- 2001-07-26 ES ES01959231T patent/ES2251501T3/es not_active Expired - Lifetime
- 2001-07-26 HU HU0301699A patent/HUP0301699A3/hu unknown
- 2001-07-26 KR KR10-2003-7001155A patent/KR20030060872A/ko not_active Application Discontinuation
- 2001-07-26 RU RU2003103706/04A patent/RU2003103706A/ru not_active Application Discontinuation
- 2001-07-26 IL IL15354701A patent/IL153547A0/xx unknown
-
2003
- 2003-01-02 ZA ZA200300039A patent/ZA200300039B/en unknown
- 2003-01-22 IS IS6695A patent/IS6695A/is unknown
- 2003-01-24 NO NO20030393A patent/NO20030393L/no not_active Application Discontinuation
- 2003-01-24 EC EC2003004453A patent/ECSP034453A/es unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0301699A3 (en) | 2004-03-29 |
WO2002008199A3 (en) | 2002-06-13 |
KR20030060872A (ko) | 2003-07-16 |
US6541639B2 (en) | 2003-04-01 |
RU2003103706A (ru) | 2004-08-10 |
ECSP034453A (es) | 2003-03-31 |
BR0112746A (pt) | 2003-09-09 |
DE60114424D1 (de) | 2005-12-01 |
JP2004504384A (ja) | 2004-02-12 |
IL153547A0 (en) | 2003-07-06 |
NZ523271A (en) | 2005-01-28 |
HUP0301699A2 (hu) | 2003-12-29 |
MXPA03000686A (es) | 2003-06-06 |
US20020099225A1 (en) | 2002-07-25 |
WO2002008199A2 (en) | 2002-01-31 |
ZA200300039B (en) | 2004-04-02 |
ES2251501T3 (es) | 2006-05-01 |
CA2417426A1 (en) | 2002-01-31 |
EP1307431A2 (en) | 2003-05-07 |
NO20030393L (no) | 2003-03-24 |
ATE307804T1 (de) | 2005-11-15 |
PL361233A1 (en) | 2004-10-04 |
DE60114424T2 (de) | 2006-07-27 |
CN1444565A (zh) | 2003-09-24 |
AU2001280813A1 (en) | 2002-02-05 |
EP1307431B1 (en) | 2005-10-26 |
IS6695A (is) | 2003-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030393D0 (no) | Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler | |
PT1131318E (pt) | Processo para a producao de pirazoles 5-substituidos utilizando ditietanos | |
GB0130341D0 (en) | Compounds | |
ATE328874T1 (de) | Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren | |
NO20005224D0 (no) | BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse | |
AU2003299585A8 (en) | Water-soluble products and methods of making and using the same | |
MXPA03008485A (es) | Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7. | |
IS7258A (is) | Arýloxýfenýl og arýlsúlfanýlfenýl afleiður | |
ATE318189T1 (de) | Reinigungsverfahren welches ultraschallwellen verwendet | |
EA200001129A2 (ru) | Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина | |
MY137541A (en) | Polymerization catalyst activators, method of preparing, and their use in polymerization processes | |
GB0011358D0 (en) | Novel use | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
AR022321A1 (es) | Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada | |
DK1200408T3 (da) | Vedhæftningsmiddel | |
NO20033921L (no) | Inhibitor av monoaminopptak | |
EP1476149A4 (en) | SUBSTITUTED HYDRAZONES AS INHIBITORS OF CYCLOOXYGENASE-2 | |
AU2002258437A1 (en) | Peptide deformylase inhibitors | |
PT1387837E (pt) | Novos derivados de azole e de triazole, processo para a sua preparacao e sua aplicacao como medicamentos anti-fungicos | |
MXPA04004526A (es) | N-metil-homocisteinas, su uso y metodo para su produccion. | |
AU2002322035A1 (en) | Peptide deformylase inhibitors | |
DE60232650D1 (de) | Peptiddeformylaseinhibitoren | |
AU2002255635A1 (en) | Peptide deformylase inhibitors | |
CY1110139T1 (el) | Γλυκοπεπτιδικα αντιβιοτικα | |
NO20033432D0 (no) | Indolinderivat og fremgangsmåte for fremstilling av det samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |